Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kazia Therapeutics Limited

1.18
+0.334939.63%
Pre-market: 1.03-0.1500-12.71%08:58 EDT
Volume:4.50M
Turnover:5.61M
Market Cap:6.60M
PE:-0.17
High:1.44
Open:0.8107
Low:0.8000
Close:0.8451
Loading ...

BRIEF-Kazia Therapeutics Says Plan To Change Ratio Of ADSs To One ADS Representing 100 Ordinary Shares

Reuters
·
15 Oct 2024

Kazia Therapeutics- Plans to Change Ratio of Adss to One Ads Representing 100 Ordinary Shares

THOMSON REUTERS
·
15 Oct 2024

Kazia Therapeutics Reveals Promising Brain Cancer Study

TIPRANKS
·
03 Oct 2024

Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society for Radiation Oncology 66th Annual Meeting

PR Newswire
·
02 Oct 2024

Kazia Therapeutics Reveals Hopeful Ovarian Cancer Study

TIPRANKS
·
23 Sep 2024

Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium

PR Newswire
·
23 Sep 2024

Kazia Therapeutics Advances Cancer Treatment Options

TIPRANKS
·
13 Sep 2024

Kazia Therapeutics Executes Deal With QIMR Berghofer Medical to Obtain Intellectual Property License

MT Newswires Live
·
12 Sep 2024

Kazia Therapeutics Executes Deal With QIMR Berghofer Medical to Obtain Intellectual Property License

MT Newswires Live
·
12 Sep 2024

BRIEF-Kazia Executes Licensing Agreement With QIMR Berghofer

Reuters
·
12 Sep 2024

Kazia Executes Licensing Agreement With Qimr Berghofer

THOMSON REUTERS
·
12 Sep 2024

Kazia Therapeutics Ltd - Receives Exclusive Worldwide License for Pi3k Inhibitor Combinations

THOMSON REUTERS
·
12 Sep 2024

KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER

PR Newswire
·
12 Sep 2024